Clinical Trials Logo

Clinical Trial Summary

This is a randomized controlled clinical trial (RCT) with a split-mouth design. After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingival professional oral hygiene of both arches performed with ultrasonic instrumentation with PEEK inserts, manual instrumentation with titanium curettes and air polishing with glycine powder. After that, the following treatment will be randomly assigned: - Ozoral Pro and Ozoral gel administration and home application for 2 peri-implant mucositis sites. - Curasept chlorhexidine gel 1% administration and domiciliary application for 14 days for 2 peri-implant contralateral sites. The study will last 2 years. Patients will be visited at: T0, after 1 month from T0 (T1), after 3 months (T2), after 6 months (T3), after 9 months (T4), after 12 months (T5), after 15 months (T6), after 18 months (T7), after 21 months (T8) and after 24 months (T9). For each time point, (except for T1), professional hygiene will be performed again. At each recall session, the following periodontal clinical indices were collected using a probe on each peri-implant site: BOP, GBI, conditions of the marginal mucosa (swelling and erythema), suppuration, migration of the marginal mucosa, PD, PI ,BS.


Clinical Trial Description

This is a randomized controlled clinical trial (RCT) with a split-mouth design, where a total of 30 patients is expected to be enrolled. After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingival professional oral hygiene of both arches performed with ultrasonic instrumentation with PEEK inserts, manual instrumentation with titanium curettes and air polishing with glycine powder. After that, the following treatment will be randomly assigned: - Ozoral Pro and Ozoral gel administration and home application for 2 peri-implant mucositis sites. - Curasept chlorhexidine gel 1% administration and domiciliary application for 14 days for 2 peri-implant contralateral sites. The study will last 2 years. Patients will be visited at: T0, after 1 month from T0 (T1), after 3 months (T2), after 6 months (T3), after 9 months (T4), after 12 months (T5), after 15 months (T6), after 18 months (T7), after 21 months (T8) and after 24 months (T9). For each time point, (except for T1), professional hygiene will be performed again. At each recall session, the following periodontal clinical indices were collected using a probe on each peri-implant site: - BOP (bleeding on probing) and GBI (gingival bleeding index) - Conditions of the marginal mucosa (swelling and erythema) - Suppuration - Migration of the marginal mucosa - PD (probing depth) - PI (plaque index) - BS (bleeding score) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05254275
Study type Interventional
Source University of Pavia
Contact
Status Active, not recruiting
Phase N/A
Start date March 22, 2022
Completion date May 27, 2024

See also
  Status Clinical Trial Phase
Completed NCT05332327 - Comparison of the Accuracy of Different Periodontal Probes for Peri-implant Pocket Registration
Enrolling by invitation NCT06063876 - Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty N/A
Completed NCT01941797 - Experimental Peri-implant Mucositis in Humans N/A
Enrolling by invitation NCT05675241 - Characterizing the Inflammation Around Dental Implants
Completed NCT04874467 - Influence of Keratinized Mucosa on Dental Implants With Mucositis N/A
Recruiting NCT05906810 - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis N/A
Enrolling by invitation NCT06137846 - Treatment of Peri-implant Mucositis and Supportive Peri-implant Therapy N/A
Completed NCT05945836 - Peri-implant Disease and Prosthetic Cement: Cross-sectional Study
Not yet recruiting NCT05897736 - Salivary Minerals in Patients With Peri-implantitis
Recruiting NCT04052373 - Peri-implantitis Implantoplasty Treatment N/A
Completed NCT03844035 - Impacts of Oral Irrigation in Patients With Periimplant Mucositis N/A
Completed NCT03533166 - Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis N/A
Completed NCT03693196 - The Effect of Different Dental Implant Surface Characteristics on Immunological and Microbiological Parameters N/A
Completed NCT03421717 - The Effect of Peri-implant Surgery and Chair-side Supportive Post Surgical Peri-implant Therapy N/A
Completed NCT03998865 - Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments N/A
Recruiting NCT05592314 - Lnfluence of the Prosthetic Emergence Profile on the Prevalence of Peri-implant Diseases: a Cross Sectional Study
Completed NCT04899986 - Chlorhexidine Gel and Peribioma Periogel Use in Peri-implant Mucositis Sites: a Split-mouth Randomized Clinical Trial. N/A
Recruiting NCT04415801 - Effect of Repeated Removal and Re-placement of Abutments Around Dental Implants N/A
Recruiting NCT04283903 - Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases
Completed NCT04215432 - Propolis Extract, Nanovitamin C and Nanovitamin E in Peri-implant Mucositis N/A